ZNF33CP

Across TCGA pan-cancer cohorts, ZNF33CP RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated ZNF33CP data layer.

The strongest signal is observed in mesothelioma (MESO), where higher ZNF33CP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF33CP expression acts as an unfavorable survival marker, although some lineages such as LGG and KIRC show a favorable association.

MESO, READ, and ESCA are the cancer types where ZNF33CP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	II,III,IV	0.146	0.430	<.001	45	view →
READ	OS	Tertile	II,III,IV	0.171	0.685	<.001	39	view →
ESCA	DFS	Quartile	II,III,IV	0.127	0.895	<.001	33	view →
UVM	DFS	Tertile	All	0.240	0.760	.020	24	view →
UCEC	OS	Tertile	All	0.799	0.882	.021	18	view →
LGG	OS	Median	All	0.933	0.856	.001	13	view →
HNSC	DFS	Tertile	IV	0.420	0.683	.007	12	view →
LIHC	OS	Tertile	II,III,IV	0.213	0.627	.041	9	view →
BRCA	OS	Tertile	All	0.429	0.609	.017	6	view →
KIRC	OS	Median	All	0.681	0.582	.032	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

ZNF33CP–MESO (DFS)

Open the MESO breakdown →